US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.304
  • +0.016+5.52%
Close Nov 29 13:00 ET
  • 0.306
  • +0.002+0.66%
Post 17:01 ET
16.68MMarket Cap-173P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
28.82%-13.98M
39.17%-12.44M
12.03%-30.45M
-16.95%-92.08M
26.12%-17.37M
22.02%-19.65M
-354.03%-20.45M
-35.62%-34.62M
-31.03%-78.73M
-1,788.35%-23.51M
Net income from continuing operations
55.49%-12.48M
36.41%-20.02M
-15.12%-30.7M
-38.65%-118.51M
-6.59%-32.34M
-20.93%-28.03M
-648.43%-31.48M
3.91%-26.67M
3.35%-85.47M
9.12%-30.34M
Depreciation and amortization
23.73%73K
28.33%77K
-27.59%42K
4.44%259K
34.43%82K
-3.28%59K
-4.76%60K
-7.94%58K
0.00%248K
-1.61%61K
Other non cash items
376.41%2.2M
464.06%2.17M
500.27%2.25M
88.40%2.68M
297.28%1.46M
28.33%462K
9.40%384K
9.01%375K
8.88%1.42M
8.90%367K
Change In working capital
-327.94%-10.57M
-69.92%2.14M
58.05%-4.89M
178.67%10.17M
255.22%10.07M
177.57%4.64M
226.87%7.11M
-178.66%-11.65M
-345.56%-12.92M
-87.51%2.83M
-Change in receivables
-91.82%451K
127.64%1.1M
139.07%1.1M
113.21%436K
-72.89%1.71M
443.79%5.51M
28.07%-3.98M
-13.15%-2.81M
-461.95%-3.3M
-68.24%6.32M
-Change in inventory
-100.65%-1K
-512.63%-392K
107.07%80K
-317.91%-438K
181.20%445K
-90.52%154K
106.12%95K
-267.21%-1.13M
107.78%201K
78.79%-548K
-Change in prepaid assets
-39.82%1.4M
-9.28%2.01M
354.74%2.36M
159.01%8.11M
96.25%4.5M
118.49%2.32M
343.04%2.22M
64.23%-928K
-243.85%-13.75M
-38.62%2.3M
-Change in payables and accrued expense
-177.67%-8.05M
-110.28%-951K
-60.67%-10.15M
-42.33%3.28M
167.80%3.24M
-141.49%-2.9M
226.85%9.25M
-1,087.19%-6.32M
656.76%5.68M
-333.09%-4.78M
-Change in other current liabilities
-1,175.73%-4.36M
--0
--0
-9.29%-1.92M
-40.66%-640K
23.15%-342K
-9.72%-474K
-9.22%-462K
-9.55%-1.76M
-9.38%-455K
-Change in other working capital
--0
--368K
--1.73M
--699K
--807K
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
28.82%-13.98M
39.17%-12.44M
12.03%-30.45M
-16.95%-92.08M
26.12%-17.37M
22.02%-19.65M
-354.03%-20.45M
-35.62%-34.62M
-31.03%-78.73M
-1,788.35%-23.51M
Investing cash flow
Cash flow from continuing investing activities
-89.20%2.5M
-53.39%15.29M
46.55%25.95M
-66.23%43.46M
-167.99%-30.21M
9.35%23.16M
10.53%32.8M
-47.03%17.71M
2,809.05%128.71M
182.91%44.42M
Net PPE purchase and sale
--0
---210K
---836K
-5,423.26%-2.38M
---2.05M
---323K
--0
--0
-238.71%-43K
--0
Net investment purchase and sale
-89.35%2.5M
-52.75%15.5M
51.27%26.79M
-64.40%45.84M
-163.37%-28.15M
10.87%23.48M
10.53%32.8M
-47.10%17.71M
2,792.39%128.75M
182.97%44.42M
Cash from discontinued investing activities
Investing cash flow
-89.20%2.5M
-53.39%15.29M
46.55%25.95M
-66.23%43.46M
-167.99%-30.21M
9.35%23.16M
10.53%32.8M
-47.03%17.71M
2,809.05%128.71M
182.91%44.42M
Financing cash flow
Cash flow from continuing financing activities
-162.19%-694K
-610K
-222.32%-685K
12,167.20%38.15M
165,695.45%36.48M
973.08%1.12M
0
18,566.67%560K
-99.33%311K
-99.95%22K
Net common stock issuance
----
----
----
--1.12M
--0
----
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
80.06%560K
-95.45%1K
-100.96%-1K
--0
18,566.67%560K
-81.03%311K
-93.10%22K
Net other financing activities
---694K
---610K
---685K
--36.47M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-162.19%-694K
---610K
-222.32%-685K
12,167.20%38.15M
165,695.45%36.48M
973.08%1.12M
--0
18,566.67%560K
-99.33%311K
-99.95%22K
Net cash flow
Beginning cash position
-15.66%50.74M
1.46%48.5M
-16.32%53.68M
362.80%64.15M
49.91%64.78M
27.65%60.16M
119.56%47.8M
362.80%64.15M
-56.81%13.86M
84.68%43.21M
Current changes in cash
-363.25%-12.18M
-81.85%2.24M
68.28%-5.19M
-120.81%-10.47M
-153.02%-11.1M
218.25%4.63M
-51.26%12.36M
-306.73%-16.35M
375.85%50.29M
319.49%20.94M
End cash Position
-40.48%38.56M
-15.66%50.74M
1.46%48.5M
-16.32%53.68M
-16.32%53.68M
49.91%64.78M
27.65%60.16M
119.56%47.8M
362.80%64.15M
362.80%64.15M
Free cash flow
29.97%-13.98M
38.14%-12.65M
9.62%-31.29M
-19.91%-94.45M
17.39%-19.42M
20.74%-19.97M
-354.03%-20.45M
-35.40%-34.62M
-31.01%-78.77M
-1,731.00%-23.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 28.82%-13.98M39.17%-12.44M12.03%-30.45M-16.95%-92.08M26.12%-17.37M22.02%-19.65M-354.03%-20.45M-35.62%-34.62M-31.03%-78.73M-1,788.35%-23.51M
Net income from continuing operations 55.49%-12.48M36.41%-20.02M-15.12%-30.7M-38.65%-118.51M-6.59%-32.34M-20.93%-28.03M-648.43%-31.48M3.91%-26.67M3.35%-85.47M9.12%-30.34M
Depreciation and amortization 23.73%73K28.33%77K-27.59%42K4.44%259K34.43%82K-3.28%59K-4.76%60K-7.94%58K0.00%248K-1.61%61K
Other non cash items 376.41%2.2M464.06%2.17M500.27%2.25M88.40%2.68M297.28%1.46M28.33%462K9.40%384K9.01%375K8.88%1.42M8.90%367K
Change In working capital -327.94%-10.57M-69.92%2.14M58.05%-4.89M178.67%10.17M255.22%10.07M177.57%4.64M226.87%7.11M-178.66%-11.65M-345.56%-12.92M-87.51%2.83M
-Change in receivables -91.82%451K127.64%1.1M139.07%1.1M113.21%436K-72.89%1.71M443.79%5.51M28.07%-3.98M-13.15%-2.81M-461.95%-3.3M-68.24%6.32M
-Change in inventory -100.65%-1K-512.63%-392K107.07%80K-317.91%-438K181.20%445K-90.52%154K106.12%95K-267.21%-1.13M107.78%201K78.79%-548K
-Change in prepaid assets -39.82%1.4M-9.28%2.01M354.74%2.36M159.01%8.11M96.25%4.5M118.49%2.32M343.04%2.22M64.23%-928K-243.85%-13.75M-38.62%2.3M
-Change in payables and accrued expense -177.67%-8.05M-110.28%-951K-60.67%-10.15M-42.33%3.28M167.80%3.24M-141.49%-2.9M226.85%9.25M-1,087.19%-6.32M656.76%5.68M-333.09%-4.78M
-Change in other current liabilities -1,175.73%-4.36M--0--0-9.29%-1.92M-40.66%-640K23.15%-342K-9.72%-474K-9.22%-462K-9.55%-1.76M-9.38%-455K
-Change in other working capital --0--368K--1.73M--699K--807K--------------------
Cash from discontinued investing activities
Operating cash flow 28.82%-13.98M39.17%-12.44M12.03%-30.45M-16.95%-92.08M26.12%-17.37M22.02%-19.65M-354.03%-20.45M-35.62%-34.62M-31.03%-78.73M-1,788.35%-23.51M
Investing cash flow
Cash flow from continuing investing activities -89.20%2.5M-53.39%15.29M46.55%25.95M-66.23%43.46M-167.99%-30.21M9.35%23.16M10.53%32.8M-47.03%17.71M2,809.05%128.71M182.91%44.42M
Net PPE purchase and sale --0---210K---836K-5,423.26%-2.38M---2.05M---323K--0--0-238.71%-43K--0
Net investment purchase and sale -89.35%2.5M-52.75%15.5M51.27%26.79M-64.40%45.84M-163.37%-28.15M10.87%23.48M10.53%32.8M-47.10%17.71M2,792.39%128.75M182.97%44.42M
Cash from discontinued investing activities
Investing cash flow -89.20%2.5M-53.39%15.29M46.55%25.95M-66.23%43.46M-167.99%-30.21M9.35%23.16M10.53%32.8M-47.03%17.71M2,809.05%128.71M182.91%44.42M
Financing cash flow
Cash flow from continuing financing activities -162.19%-694K-610K-222.32%-685K12,167.20%38.15M165,695.45%36.48M973.08%1.12M018,566.67%560K-99.33%311K-99.95%22K
Net common stock issuance --------------1.12M--0--------------0--0
Proceeds from stock option exercised by employees --0--0--080.06%560K-95.45%1K-100.96%-1K--018,566.67%560K-81.03%311K-93.10%22K
Net other financing activities ---694K---610K---685K--36.47M------------------------
Cash from discontinued financing activities
Financing cash flow -162.19%-694K---610K-222.32%-685K12,167.20%38.15M165,695.45%36.48M973.08%1.12M--018,566.67%560K-99.33%311K-99.95%22K
Net cash flow
Beginning cash position -15.66%50.74M1.46%48.5M-16.32%53.68M362.80%64.15M49.91%64.78M27.65%60.16M119.56%47.8M362.80%64.15M-56.81%13.86M84.68%43.21M
Current changes in cash -363.25%-12.18M-81.85%2.24M68.28%-5.19M-120.81%-10.47M-153.02%-11.1M218.25%4.63M-51.26%12.36M-306.73%-16.35M375.85%50.29M319.49%20.94M
End cash Position -40.48%38.56M-15.66%50.74M1.46%48.5M-16.32%53.68M-16.32%53.68M49.91%64.78M27.65%60.16M119.56%47.8M362.80%64.15M362.80%64.15M
Free cash flow 29.97%-13.98M38.14%-12.65M9.62%-31.29M-19.91%-94.45M17.39%-19.42M20.74%-19.97M-354.03%-20.45M-35.40%-34.62M-31.01%-78.77M-1,731.00%-23.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data